Costa Rica: medical and donor requirements in a surrogacy plan
Short answer
The published Costa Rican IVF framework is clearer on conventional in-vitro fertilization (IVF) and third-party gametes than on gestational surrogacy. Executive Decree No. 39210-MP-S describes IVF as fertilization outside the body followed by transfer to the maternal uterus. It sets rules for defined IVF recipients, donor screening, written consent, records and embryo handling. Those rules should not be presented as a complete authorization for a gestational-carrier arrangement. Separate the clinic’s authority to perform a particular IVF procedure from the legal status of the carrier arrangement, contract, intended parents and child. The medical and donor provisions alone do not settle those wider questions. [S1]
What the official sources establish—and what remains open
The main primary text is Decree 39210-MP-S. Official materials also identify a technical standard for IVF establishments (Decree 39616-S) and a separate establishment-habilitation standard (Decree 39646-S). The Ministry’s 2025 consultation page listed a proposal to amend section 4.1.1 and repeal sections 4.3.5.16 and 4.3.5.17 of the latter standard. The current consolidated SINALEVI text records that sections 4.3.5.16 and 4.3.5.17 were repealed under Article 2 of Executive Decree No. 45317 dated 16 October 2025; the status of the separate proposed amendment to section 4.1.1 remains unverified. In the official sources, no current surrogacy-specific medical/donor checklist was verified. Current consolidated texts, later gazettes and case law need local review. [S1–S5, S11]
What recent court decisions do—and do not—decide
The legal status of Decree 39210-MP-S has a procedural history that should not be omitted. On 3 February 2016, Costa Rica’s Constitutional Chamber declared the decree unconstitutional on formal-legality grounds. On 26 February 2016, in its supervision of compliance with Artavia Murillo, the Inter-American Court of Human Rights held that the IVF ban could not continue to produce legal effects and required immediate access to IVF. In its 2019 supervision resolution, the Court noted the State’s report that Decree 39210-MP-S remained in force and had not been amended. These decisions must be read together. They concern access to IVF, not blanket authorization of gestational surrogacy. Costa Rican counsel should confirm the current domestic effect before the decree is relied on in a specific case. [S6–S8]
Later rulings address narrower issues. In Resolution No. 15172-2025 (20 May 2025), the Constitutional Chamber ordered the Costa Rican Social Security Fund (CCSS) to define and approve technical guidelines for the safe transfer of cryopreserved embryos in a dispute about moving embryos from a public IVF unit to a private clinic. It did not generally authorize surrogacy or set donor-testing requirements. In Resolution No. 13258-2026 (21 April 2026), the Court partially granted an amparo concerning missing embryo records and delay in deciding a request connected with altruistic gestational surrogacy. It ordered the hospital to provide the requested information within 10 days and decide the request within one month, but did not authorize the proposed procedure on its merits or establish a general surrogacy pathway. Before relying on either judgment, ask Costa Rican counsel to review the full decisions and verify subsequent CCSS/Ministry guidance and any later amendments. [S9, S10]
Who can receive IVF under Decree 39210-MP-S?
Article 2 of Decree 39210-MP-S identifies IVF recipients as either an adult couple where at least one person has infertility and neither has been judicially declared incapable, or an adult woman without a partner who has infertility and has not been judicially declared incapable. It also says other medical treatments for the infertility should first have been exhausted, unless an express medical opinion shows they are not viable. These are recipient criteria for the IVF treatment described in the decree. They are not, by themselves, a complete eligibility test for intended parents in a surrogacy arrangement, nor do they define the medical or legal status of a gestational carrier. [S1]
Third-party donor eligibility
For heterologous IVF, Article 4 describes a third-party donor as an adult and uses the Spanish phrase “en libertad de estado.” Article 5 separately says the donor must be an adult and must not have been judicially declared incapable. The decree also links heterologous IVF to the inability to use the homologous form for biological reasons and to the case of a woman without a partner. The exact current application of “en libertad de estado” should be confirmed with Costa Rican counsel; do not rely on a loose translation, an agency summary or a clinic’s verbal explanation. A donor rule written for the decree’s IVF model should not automatically be treated as a complete rule for every surrogacy structure. Article 4 also states that a donor in heterologous IVF acquires no rights or obligations inherent to filiation or paternity by reason of that technique. That rule concerns donor status under the decree’s IVF model; it does not establish who will be recognized as a child’s legal parent in a gestational-carrier arrangement. [S1]
Medical screening of gamete donors
Article 5 requires physical and diagnostic examinations of the donor sufficient to ensure that the donor does not carry diseases that could affect the recipient or offspring. This is a binding health-protection duty expressed by its purpose. Article 5 does not itself provide a complete named list of laboratory tests, a universal genetic-screening panel, a fixed upper donor age or a single validity period for test results. Other current technical rules, Ministry protocols and medically justified clinic procedures may add requirements. Because the current consolidated annex to Decree 39646-S and the outcome of the 2025 consultation were not fully verified, this guide does not present any particular test panel as the definitive statutory list. [S1, S3, S4]
Donor registers and confidentiality
Article 5 requires each authorized establishment to maintain a donor register and the Ministry of Health to maintain a national donor register. Articles 5 and 13 address protection and confidentiality of donor and clinical information, and Article 5 refers to Personal Data Protection Law No. 8968. Confidentiality is not the same as a guarantee of absolute anonymity in every circumstance. Ask which data are collected, how long samples and records are retained, who can access them, whether donor identity can ever be disclosed, and what rules apply if a child or a court later requests information. The clinic should answer by reference to current law and its actual record-management protocol, not simply promise that all information is permanently anonymous. [S1]
Informed consent and withdrawal
Article 15 requires recipients to receive complete and clear information and give free, voluntary and informed consent in writing before IVF. Where the recipient is a couple, each member must consent individually. In heterologous IVF, the third-party donor must also give informed consent to donate. The decree says consent can be revoked by an express act. Before signing, obtain every form in a language each person understands and ask how revocation works at each stage: before collection, after collection, after fertilization, during storage and before transfer. Do not assume that revocation has the same practical consequences for unused gametes and embryos; request a written explanation and specific legal advice. [S1]
Clinic authorization and technical standards
Article 3 limits IVF to a medical establishment meeting the Ministry of Health’s requirements. Article 6 gives the Ministry authorization, inspection and control functions under the General Health Law. Official materials identify Decree 39616-S as a technical standard for establishments performing IVF and embryo transfer, and Decree 39646-S as a separate establishment-habilitation standard. Verify the clinic’s current authorization directly with the Ministry and confirm that its permitted scope covers the proposed procedure, laboratory work and gamete handling. Check the responsible specialist’s professional registration and reproductive-medicine credentials. A general medical licence, attractive website, overseas referral network or claim that a clinic “works with surrogates” is not a substitute for checking the specific authorization and legal basis. [S1–S4]
Why a carrier needs a separate legal and clinical assessment
Do not treat the intended recipient and the gestational carrier as the same legal or clinical subject. Article 9 assigns the Ministry the task of determining pre-treatment clinical and diagnostic examinations for IVF recipients, while Article 12 provides for interdisciplinary care to protect the woman’s physical and psychological health. The decree’s definition of IVF, however, describes transfer to the maternal uterus; the text does not set out a complete carrier-specific assessment pathway. A carrier may require individual obstetric, medical, psychological and informed-consent assessments, but the exact mandatory tests and their legal basis must be verified rather than guessed. Ask the clinic to identify, in writing, which tests arise from binding law, which from the current technical standard, which from professional judgment, and which from clinic policy. [S1–S4]
Embryo transfer and handling
Article 16 says no more than two fertilized ova may be transferred to the woman’s uterine cavity in one reproductive cycle; using the maximum is allowed only when the responsible professional team considers it technically appropriate. The same article says the number of ova fertilized should be the minimum needed to support the planned transfer under scientific standards. Article 19 lists prohibitions concerning fertilized ova, including disposal, commercialization, experimentation, genetic selection, fission, genetic alteration, cloning and destruction; it also addresses post-mortem insemination or transfer without express informed consent. These provisions concern the IVF treatment regulated by the decree. They should not be used alone to assume how every rule applies to a gestational-carrier arrangement. Obtain the clinic’s written embryo-storage and disposition policy and a case-specific legal analysis. [S1]
Decision matrix: law, open questions and next action
Use the matrix below as a starting point, not as a final legal opinion. The binding text establishes a donor’s adult status, a donor examination duty, written consent, registers and Ministry oversight. It does not, in the provisions reviewed, answer every operational question about a gestational carrier or provide one universal donor-testing panel. A separate technical/establishment standard exists, and the Ministry listed a proposed change to parts of it in 2025; the final legal status of that proposal must be checked. Keep four categories distinct: (1) statute or decree; (2) current technical standard or official protocol; (3) the clinic’s internal policy; and (4) an individual clinician’s documented medical judgment. A clinic may apply stricter evidence-based screening than the express minimum, but it should not mislabel its own policy as a statutory requirement. [S1–S4]
| Issue | Verified legal floor | What still needs checking |
|---|---|---|
| Donor eligibility | Adult; not judicially declared incapable; Article 4 also uses “en libertad de estado”. | Current meaning/application of the civil-status phrase and any added current requirements. |
| Donor medical tests | Physical and diagnostic examinations to prevent disease affecting recipient or offspring. | Exact test panel, test validity, age criteria and any genetic/infectious-disease protocol. |
| Consent and records | Written informed consent; donor consent; establishment and national donor registers; confidentiality. | Withdrawal at each stage, identity disclosure, retention and sample-use rules. |
| Clinic | Must meet Ministry requirements; Ministry has authorization and inspection powers. | Current authorization scope, responsible specialist and current technical standard. |
| Gestational carrier | No complete carrier-specific checklist verified in the reviewed IVF decree. | Specific legal basis, carrier-specific assessment, contract and parentage route. |
Documents to request before treatment
Before treatment or payment, use the checklist below to obtain a documented basis for each medical and legal step.
- Get the current clinic authorization and ask the Ministry to confirm the permitted scope. Obtain the current consolidated versions of Decrees 39210-MP-S, 39616-S and 39646-S and any final amendment published after the 2025 consultation.
- Ask the clinic for a person-by-person medical checklist: intended parent(s), egg donor, sperm donor and carrier. For every test, record whether it comes from binding law, an official technical standard/protocol, clinic policy or an individual clinician’s judgment.
- Collect all written consent forms, donor eligibility records, screening results, privacy/retention policy, storage terms, withdrawal procedure and embryo-disposition instructions before medication, retrieval, fertilization or transfer.
- Have Costa Rican counsel address the legality of the exact carrier arrangement, the effect of any contract, and the child’s parentage, birth registration, nationality and exit/travel documents in every relevant country.
Red flags in a clinic’s explanation
The following statements are red flags because they merge distinct legal questions or treat unverified material as binding law.
- “IVF is available, therefore surrogacy is authorized.” The decree’s IVF definition and recipient rules do not prove that conclusion.
- “The donor has no parental rights, therefore the intended parents are automatically legal parents.” Donor status and parentage of a child born to a carrier are separate questions.
- “These are statutory tests” without an article or current technical provision. Ask whether each item is law, official protocol, clinic policy or individualized medical judgment.
- “The clinic is licensed” without current evidence that the authorization covers IVF-TE and the proposed gamete/embryo handling.
- Reliance on a bill or a 2025 consultation draft as if it were already in force. Verify final publication and effective date in the official Gazette.
Practical sequence before committing
A safe sequence is: first, obtain a current Costa Rican legal opinion on whether the proposed carrier arrangement may lawfully be performed and how the applicable rules treat the carrier, donors and intended parents. Second, independently verify the clinic’s authorization and the current Decrees 39210-MP-S, 39616-S and 39646-S, including any final action following the 2025 consultation. Third, obtain the clinical testing plan and separate each binding requirement from clinic policy or individualized medical judgment. Fourth, review consent, privacy, sample/embryo storage and withdrawal terms before signing. Fifth, obtain separate advice on parentage, civil registration, nationality and travel for the country where the child will be born and every country where recognition or entry is sought. Do not start irreversible clinical steps or make major non-refundable payments while the core legal route remains unresolved. [S1–S5]
Conclusion
The defensible conclusion is narrow: Costa Rica’s IVF decree contains express donor eligibility, disease-screening, consent, recordkeeping, clinic-oversight and embryo-handling provisions. Those rules matter, but they do not by themselves establish that a gestational-carrier program is permitted, that a particular donor checklist is exhaustive, or that intended parents will be recognized as legal parents. The current consolidated SINALEVI text confirms that sections 4.3.5.16 and 4.3.5.17 were repealed by Decree No. 45317 of 16 October 2025; however, the complete current annex and the status of the proposed amendment to section 4.1.1 still require verification. Treat this article as a guide to the legal questions, not legal clearance. Before a program proceeds, a Costa Rican lawyer should confirm the operative texts and apply them to the exact medical pathway, participants and intended parentage outcome. [S1–S5, S11]
Official sources
- [S1] Decreto Ejecutivo No. 39210-MP-S, Autorización para la realización de la técnica de reproducción asistida de fecundación in vitro y transferencia embrionaria — Official Gazette text used for the core IVF and donor provisions.
- [S2] Decreto Ejecutivo No. 39616-S, Norma para establecimientos de salud que realizan FIV-TE — Official technical standard for IVF establishments; not treated as a complete donor-test list.
- [S3] Ministerio de Salud de Costa Rica, Legislación sanitaria— Ministry page listing Decree 39646-S; the listing is checked, not the full current annex.
- [S4] Ministerio de Salud de Costa Rica, Consulta pública de normativa 2025— Official consultation page showing the 2025 proposal; the consolidated text now confirms repeal of sections 4.3.5.16 and 4.3.5.17, while adoption of the separate section 4.1.1 amendment remains unverified.
- [S5] Ministerio de Salud de Costa Rica, Memoria institucional 2016 — Ministry report on the 2016 Inter-American Court compliance order; historical confirmation only.
- [S6] Sala Constitucional de Costa Rica, Resolución n.º 2016-001692 (3 de febrero de 2016) — Official domestic ruling annulling Decree 39210-MP-S on formal-legality grounds; read alongside the Inter-American Court’s later compliance order.
- [S7] Corte Interamericana de Derechos Humanos, Caso Artavia Murillo y otros vs. Costa Rica, Resolución de supervisión de cumplimiento (26 de febrero de 2016) — Official compliance resolution requiring immediate access to IVF and stating that the ban could not continue to produce legal effects; it does not decide surrogacy.
- [S8] Corte Interamericana de Derechos Humanos, Casos Artavia Murillo y Gómez Murillo vs. Costa Rica, Resolución de supervisión de cumplimiento (22 de noviembre de 2019) — Official compliance follow-up recording the State’s report that Decree 39210-MP-S remained in force and had not been amended.
- [S9] Sala Constitucional de Costa Rica, Resolución n.º 15172-2025 (20 de mayo de 2025) — Official ruling on embryo transfer from a public IVF unit to a private clinic; requires technical guidelines for safe transfer, not general surrogacy approval.
- [S10] Sala Constitucional de Costa Rica, Resolución n.º 13258-2026 (21 de abril de 2026) — Official ruling on embryo records and delay in deciding a request linked to altruistic gestational surrogacy; procedural relief, not substantive authorization.
- [S11] Sistema Costarricense de Información Jurídica (SCIJ/SINALEVI), versión vigente y consolidada del Decreto Ejecutivo n.º 39646-S— The current consolidated legal-database entry records sections 4.3.5.16 and 4.3.5.17 as repealed by Decree 45317; adoption of the proposed amendment to section 4.1.1 remains unverified.
